GPI-5000

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameGPI-5000
Drug Alias Name2-PMPA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstate-Specific Membrane Antigen inhibitors
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsNeuralgiaDiabetic NeuropathiesNeurodegenerative Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMGI GP Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMGI GP Inc
Active IndicationsN/A
Inactive IndicationsNeuralgiaDiabetic NeuropathiesNeurodegenerative Diseases

Other Information

ATC CodeN/A
Related LinksN/A